Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005 /

This Statistical Brief examines trends for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly know as statins, for the years 2000 and 2005. The data included in this brief are derived from 2000 and 2005 data for the U.S. civilian noninstitutionalized population from the H...

Full description

Bibliographic Details
Main Author: Stagnitti, Marie N.
Corporate Authors: United States. Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey (U.S.)
Format: Government Document eBook
Language:English
Published: [Rockville, Md.] : Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, [2008]
Series:Statistical brief (Medical Expenditure Panel Survey (U.S.)) ; #205.
Subjects:
Online Access:https://purl.fdlp.gov/GPO/LPS102115
Description
Summary:This Statistical Brief examines trends for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly know as statins, for the years 2000 and 2005. The data included in this brief are derived from 2000 and 2005 data for the U.S. civilian noninstitutionalized population from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC). The brief compares 2000 and 2005 total expenditures, total number of purchases, and total number of persons purchasing, as well as average total expenditure and average number of purchases of statins for those with one or more statin purchases.
Item Description:Title from title screen (viewed Sept. 12, 2008).
"May 2008."
Electronic resource.
Physical Description:6 unnumbered pages : digital, PDF file.
Format:Mode of access: Internet from the MEPS AHRQ web site. Address as of 9/12/2008: http://www.meps.ahrq.gov/mepsweb/data%5Ffiles/publications/st205/stat205.pdf ; current access available via PURL.
Bibliography:Includes bibliographical references.